Fresh analysis indicates that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Research printed in a major medical journal shows that while obese people can lose a large proportion of their total mass while on the medication, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"Users purchasing such treatments must be informed of the potential of fast rebound weight gain when the therapy concludes," warns researcher Dr. Susan Jebb.
Such speed of recovery means a return to original weight within about 18 months.
Weighing Approaches
The research, which looked at 37 of studies involving over 9,000 of participants, compared the results of the injectable medications with conventional dieting.
Scientists point out that individuals who lose weight through diet and exercise usually experience a more gradual weight regain—perhaps 100 grams monthly—post-intervention.
Explaining the Rapid Regain
Experts propose the way of the drugs accounts for the heightened rebound.
The injections mimic a natural hormone called glucagon-like peptide-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its own natural hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement results in hunger is no longer kept in check, making excessive eating far more likely."
An Ongoing Disease?
The NHS recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts say that, given the high risk of weight regain, the therapy might need to be long-term.
This view is reinforced by drug manufacturers, who say that the findings "highlight the chronic nature of obesity," comparing it to managing diseases like high blood pressure.
Patient Testimonies
Users who have discontinued the jabs explain a powerful return of appetite.
"I experienced a switch activating and you become starving," said one woman.
This challenge is exacerbated if individuals have not developed sustainable lifestyle or habit modifications during treatment.
Growing Use
Figures indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Adoption is greater among women compared to males.
- The 40s and 50s demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Ultimately, clinicians caution that while these medications are powerful agents for shedding pounds, they are not a permanent fix and lasting health benefits likely depends on integrated lifestyle management.
